Physician profile
Mark T Herbert
NPI 1902875123
$1,306.40
in general payments reported to CMS, 2019-2025
21 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.34 · 2021: $52.94 · 2022: $248 · 2023: $341 · 2024: $247 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $317.83 | 2021-2025 | |
| Viiv Healthcare Company | $150.54 | 2022-2025 | Dovato, Rukobia |
| La Jolla Pharmaceutical Company | $146.22 | 2025 | Zevtera |
| Novo Nordisk INC | $128.01 | 2022-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $104.55 | 2023 | Shingrix |
| Abbvie INC. | $104.09 | 2022-2025 | |
| Lilly USA, LLC | $42.33 | 2022 | |
| Janssen Biotech, INC. | $41.73 | 2023 | Symtuza |
| Shionogi INC | $29.03 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.17 | 2022-2024 | Jardiance |
| Melinta Therapeutics, LLC | $28.06 | 2019 | |
| Abbott Laboratories | $22.95 | 2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $22.59 | 2025 | Cologuard Collection Kit |
| Verity Pharmaceuticals INC. | $21.35 | 2024 | Tlando |
| Amgen INC. | $20.15 | 2025 | Repatha, Otezla |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.72 | 2024 | Xifaxan |
| Astrazeneca Pharmaceuticals Lp | $18.61 | 2025 | Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $17.59 | 2023 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $15.60 | 2023 | |
| Emd Serono, INC. | $14.58 | 2019 | |
| Merck Sharp & Dohme LLC | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Herbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.